M518101
AssetAlso M-5181, Pefcalcitol
Vitamin D receptor agonist formulation for skin disorders
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- VDR
- 1
- Indication
- 354
- Trials
- 1
- Developer
Indications
1Plaque psoriasis
Phase 3, Completed, NCT01989429, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials354
- Evidence for its targets2
- Competitors6
- Aging relevance1
- Signals5
Every asset’s record: target, stage, trials and the evidence behind it.